Hg, the Manager of HgCapital Trust plc (the “Company”), has announced today an investment in MediFox, a leading provider of software solutions to outpatient and inpatient care providers and therapy practices in Germany. The terms of the transaction were not disclosed.
HgCapital Trust plc will invest approximately £8.0 million in MediFox, with other institutional clients of Hg investing alongside the Company through the Mercury 2 Fund.
The Company, whose shares are listed on the London Stock Exchange, gives private and institutional investors the opportunity to participate in all Hg’s investments.
Based on the 30 April 2018 NAV, the Company’s liquid resources available for future deployment, including all announced transactions, are estimated to be £153 million (21% of the 30 April 2018 NAV of £712.8 million). In addition, the Company has access to an £80 million standby facility, which is currently undrawn. The investment will reduce the Company’s pro-forma outstanding commitments to invest in Hg transactions over the next four to five years to approximately £595 million.